Trademarkia Logo

Canada

C$
Trademark Search in Canada
Kintai THERAPEUTICS

View On IC.GC.CA

Kintai THERAPEUTICS
ABANDONED SECTION 36

on 8 Sept 2021

Last Applicant/ Owned by

Senda Biosciences, Inc.

20 Acorn Park DriveCambridge MA 02140

US

Serial Number

1999490 filed on 17th Oct 2019

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

Kintai THERAPEUTICS

Trademark usage description

therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, ca Read More

Vienna Information

7 . 11 . 1

BridgesPonts

26 . 1 . 1

CirclesCercles

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

26 . 2 . 7

Semi-circles, semi-ellipsesDemi-cercles, demi-ellipses

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

26 . 11 . 14

Dotted lines or bandsLignes ou bandes pointillées

24 . 17 . 1

Punctuation marksSignes de ponctuation

24 . 17 . 2

DotsPoints

Classification Information

Class [005]
Therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; pharmaceutical preparations for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; therapeutic pharmaceuticals for modulating metabolism; pharmaceutical preparations and agents to modulate metabolism; pharmaceutical agents that modulate metabolism for scientific and research use.

Classification kind code

11

Class [042]
Research and development in the field of computational biology, biotechnology and pharmaceuticals.

Classification kind code

11

Mark Details

Serial Number

1999490

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 25th Nov 2020		Search Recorded
Submitted for opposition 20
on 25th Nov 2020		Examiner's First Report
Submitted for opposition 223
on 25th Nov 2020		Total Provisional Refusal
Submitted for opposition 135
on 21st Oct 2020		Amendment to Application
Submitted for opposition 256
on 5th Oct 2020		Notification of Possible Opposition Sent
Submitted for opposition 257
on 5th Dec 2019		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 4th Dec 2019		Formalized
Submitted for opposition 1
on 4th Dec 2019		Created
Submitted for opposition 228
on 17th Oct 2019		International Registration
Submitted for opposition 30
on 17th Oct 2019		Filed